BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Seegene Unveils Blueprint for the Future of Molecular Diagnostics

Along with three solutions, he also introduced the company's automated, AI-enabled platform with a standard development tool that will empower users to eas...

January 13, 2022 | News

Illumina collaborates with Nashville Biosciences to accelerate medicines development

Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC)...

January 11, 2022 | News

Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems

PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The deal will i...

January 07, 2022 | News

Imvaq Therapeutics Signs a Service and Commercial Product License to Use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform

Under this agreement, ProBioGen develops a scalable process and granted Imvaq® a license to use ProBioGen's AGE1.CR.pIX cell line for the man...

January 07, 2022 | News

Illumina Enters Co-Development Partnership with SomaLogic

Illumina, Inc. (NASDAQ: ILMN) today announced it has entered into a definitive co-development agreement with SomaLogic to bring the SomaScan® Prot...

January 06, 2022 | News

GC Cell seeks to expand global availability of Immuncell-LC® for liver cancer

Rivaara Immune to lead development and commercialization in India GC Cell (KOSDAQ:144510) and Rivaara Immune Private Limited today announced that they hav...

January 05, 2022 | News

Alamar Biosciences partners with Abcam to drive understanding of the human proteome

Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and othe...

January 05, 2022 | News

Ionis and AstraZeneca close deal to develop and commercialize eplontersen

Ionis' investigational antisense medicine for the treatment of transthyretin amyloidosis (ATTR), following expiration of the waiting period under the Hart-...

January 03, 2022 | News

Covovax Receive EUA for COVID-19 Vaccine in India

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

December 29, 2021 | News

Theramex announces an agreement with Enzene Biosciences Limited for the development and commercialisation of Tocilizumab

Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, has entered into an agreement with Enzene Biosciences Limit...

December 24, 2021 | News

Clarivate Acquires Patient Connect To Provide Patient-Centric Solutions

 Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it...

December 23, 2021 | News

Merck Expands Neuroinflammatory Pipeline with Acquisition of Chord Therapeutics

Acquisition provides opportunity to develop cladribine in generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD) Cladrib...

December 22, 2021 | News

BeiGene expands commercial portfolio in China

Strategic collaboration expected to advance clinical development of ociperlimab in combination with tislelizumab, including initiation and funding by Novar...

December 22, 2021 | News

Microba Life Sciences Becomes First Australian Microbiome Company Granted ISO15189 Accreditation by NATA

he hypothesis-free testing method, MetaPanelTM, can identify multiple pathogens simultaneously from a single sample and was developed in partnership with A...

December 20, 2021 | News

Stay Connected